HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Ming Su Selected Research

Xiao-Ming Su Research Topics

Disease

3Neoplasms (Cancer)
02/2021 - 12/2011
2Prolactinoma (Prolactinomas)
11/2013 - 02/2013
2Prostatic Neoplasms (Prostate Cancer)
07/2013 - 06/2012
1Stomach Neoplasms (Stomach Cancer)
02/2021
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
06/2012
1Neoplasm Metastasis (Metastasis)
06/2012

Drug/Important Bio-Agent (IBA)

2EnzymesIBA
02/2021 - 12/2011
2Proteins (Proteins, Gene)FDA Link
06/2012 - 12/2011
1Protein Isoforms (Isoforms)IBA
02/2021
1Succinate Dehydrogenase (Fumarate Reductase)IBA
02/2021
1DNA (Deoxyribonucleic Acid)IBA
02/2021
1Mitochondrial DNA (mtDNA)IBA
02/2021
1Glucose (Dextrose)FDA LinkGeneric
02/2021
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
02/2021
1HexokinaseIBA
02/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2021
1Pyruvate KinaseIBA
02/2021
1Phosphodiesterase 5 InhibitorsIBA
11/2013
1AndrogensIBA
07/2013
1Arsenic Trioxide (Trisenox)FDA Link
07/2013
1ProlactinIBA
02/2013
1Cadherins (E-Cadherin)IBA
06/2012
1alpha Catenin (alpha E-Catenin)IBA
06/2012
1Transforming Growth Factor beta (TGF-beta)IBA
12/2011
1salicylhydroxamic acid (SHAM)IBA
12/2011
1ImmunosorbentsIBA
12/2011
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2011
14- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA
12/2011

Therapy/Procedure

2Therapeutics
11/2013 - 06/2012